SHP2 inhibition displays efficacy as a monotherapy and in combination with JAK2 inhibition in preclinical models of myeloproliferative neoplasms
Article in American Journal of Hematology (March 2024)
The most recent citing publications are shown below. View all 39 publications that cite this research output on Dimensions.
Article in American Journal of Hematology (March 2024)
Article in JCO Precision Oncology (February 2024)
Article in Blood Cancer Discovery (July 2023)